These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Welcome, ladies and gentlemen, to AstraZeneca's full-year and Q4 2024 results conference call for investors and analysts. Before I hand over to AstraZeneca, I'd like to read the safe harbor statement.

Meanwhile, a reserve population of progenitor-like T RM cells continues to lie low in the crypts. "These cells can replenish the pool of effector T cells, so the immune system keeps them as back ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

Also entered into collaboration and option agreement with AbbVie to develop novel tumor-activated immunotherapies, including masked T cell ...

Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...

Using both mouse experimental colitis models and IBD patient biopsies, here the authors implicate increased tissue factor activity on colitogenic T cells as a potential link. Although effector ...

Because of its lineage-specific expression, significant efforts have been made to develop chimeric antigen receptor T-cell (CAR-T) therapies targeting CLDN18.2. These therapies have shown encouraging ...

Exploratory study of TAS-102 combined with intermittent administration of fruquintinib in the treatment of third-line metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Unfortunately, there were many anime fans who weren’t thrilled with the design of “Cell Max,” the latest and ultimate creation of the Red Ribbon Army. In a surprising turn of events ...